A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache
Status:
Recruiting
Trial end date:
2024-05-30
Target enrollment:
Participant gender:
Summary
Medication overuse headache (MOH) is a type of headache caused by excessive use of acute
headache or migraine medications (medications used to treat a headache or migraine once it
begins). Treatment of MOH usually involves reducing the dose of or discontinuing acute
medications.
Eptinezumab is a medication used for the preventive treatment of migraine in adults. The main
goals of this trial are to learn whether eptinezumab helps reduce the number of days with
migraine, the number of days with headache, and acute medication use in adults who have
migraine and MOH.